Skip to main content
Clinical Trials/NCT01118884
NCT01118884
Unknown
Phase 3

Sedative Effects of Oral Midazolam in Comparison Promethazine With Nitrous Oxide/Oxygen on Behavior Management of Uncooperative Children Receiving Dental Treatment

Shahid Beheshti University1 site in 1 country20 target enrollmentJune 2009
InterventionsPromethazine

Overview

Phase
Phase 3
Intervention
Promethazine
Conditions
Conscious Sedation
Sponsor
Shahid Beheshti University
Enrollment
20
Locations
1
Primary Endpoint
Behavior change
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to compare the safety and efficacy of sedation using orally administered midazolam and promethazine with nitrous oxide/oxygen in uncooperative children receiving dental treatments.

Detailed Description

The effectiveness of oral midazolam in pediatric dentistry is controversial. Usefulness of midazolam alone is limited to short-duration procedures, and we are needed to identify safe oral conscious regiments which permit longer duration procedures in dental treatments especially in Pediatric dentistry. Promethazine is a long-acting (4-12 hr) anti-histaminic, H1 antagonist drug which acts as a central nervous system depressant and showing itself to be a weak anxiolytic drug. The hypothesis to be tested is whether promethazine would improve the patients behavior during dental procedures without affecting vital signs, thus enabling longer periods of moderate or conscious sedation.

Registry
clinicaltrials.gov
Start Date
June 2009
End Date
May 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy patients who are in ASA class 1 group
  • Age of the patients must be between 36-96 months
  • Uncooperative children who are in groups 1 or 2 according to Frankel's classification

Exclusion Criteria

  • Tonsil hypertrophy
  • History of allergies
  • Drooling or nocturnal snoring

Arms & Interventions

sedation

20 healthy uncooperative children aged 36-96 months were examined in a cross-over study design , each patient served as his/her own control. Each patient was assigned randomly to received 1 of 2 drug regimens for initial sedation session and the other regimen administered at second session which was one week later.

Intervention: Promethazine

Outcomes

Primary Outcomes

Behavior change

Time Frame: during dental treatment which is 30 minutes after drug ingestion

Behavior evaluation was based on a scale proposed by Houpt et al. which establishes the following scores : sleep, movement, crying , overall behavior.

Study Sites (1)

Loading locations...

Similar Trials